Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-12-16 Purchase |
2024-12-18 4:00 pm |
Cue Biopharma Inc. | CUE | PASSERI DANIEL R CHIEF EXECUTIVE OFFICER |
30,000 | $1.03 | $30,900 | 164,578 (Direct) |
View |
| 2023-08-25 Purchase |
2023-08-29 4:08 pm |
Cue Biopharma Inc. | CUE | Suri Anish PRESIDENT AND CSO |
4,000 | $2.76 | $11,040 | 135,638 (Direct) |
View |
| 2023-08-14 Purchase |
2023-08-16 4:07 pm |
Cue Biopharma Inc. | CUE | PASSERI DANIEL R CHIEF EXECUTIVE OFFICER |
3,000 | $2.86 | $8,580 | 134,578 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-03-21 Option Award |
2025-03-25 4:00 pm |
N/A 2035-03-20 |
Cue Biopharma Inc. | CUE | Millar Kerri-Ann CHIEF FINANCIAL OFFICER |
200,000 | $0 | 200,000 (Direct) |
View |
| 2025-03-21 Option Award |
2025-03-25 4:00 pm |
N/A 2035-03-20 |
Cue Biopharma Inc. | CUE | PASSERI DANIEL R CHIEF EXECUTIVE OFFICER |
450,000 | $0 | 450,000 (Direct) |
View |
| 2025-03-21 Option Award |
2025-03-25 4:00 pm |
N/A 2035-03-20 |
Cue Biopharma Inc. | CUE | Baker Daniel G. CHIEF DEVELOPMENT OFFICER |
100,000 | $0 | 100,000 (Direct) |
View |
| 2025-03-21 Option Award |
2025-03-25 4:00 pm |
N/A 2035-03-20 |
Cue Biopharma Inc. | CUE | Sandercock Colin SVP, GENERAL COUNSEL |
200,000 | $0 | 200,000 (Direct) |
View |
| 2025-03-21 Option Award |
2025-03-25 4:00 pm |
N/A 2035-03-20 |
Cue Biopharma Inc. | CUE | Warren Lucinda CHIEF BUSINESS OFFICER |
250,000 | $0 | 250,000 (Direct) |
View |
| 2025-03-21 Option Award |
2025-03-25 4:00 pm |
N/A 2035-03-20 |
Cue Biopharma Inc. | CUE | Levisetti Matteo Chief Medical Officer |
250,000 | $0 | 250,000 (Direct) |
View |
| 2025-03-10 Option Award |
2025-03-12 4:00 pm |
N/A 2035-03-09 |
Cue Biopharma Inc. | CUE | Sarraf Pasha Director |
48,800 | $0 | 48,800 (Direct) |
View |
| 2025-01-02 Option Award |
2025-01-03 4:00 pm |
N/A 2035-01-01 |
Cue Biopharma Inc. | CUE | Verheyen Patrick Director |
24,400 | $0 | 24,400 (Direct) |
View |
| 2025-01-02 Option Award |
2025-01-03 4:00 pm |
N/A 2035-01-01 |
Cue Biopharma Inc. | CUE | Garzone Pamela Director |
24,400 | $0 | 24,400 (Direct) |
View |
| 2025-01-02 Option Award |
2025-01-03 4:00 pm |
N/A 2035-01-01 |
Cue Biopharma Inc. | CUE | Morich Frank Director |
24,400 | $0 | 24,400 (Direct) |
View |
| 2025-01-02 Option Award |
2025-01-03 4:00 pm |
N/A 2035-01-01 |
Cue Biopharma Inc. | CUE | DRISCOLL FREDERICK W Director |
24,400 | $0 | 24,400 (Direct) |
View |
| 2025-01-02 Option Award |
2025-01-03 4:00 pm |
N/A 2035-01-01 |
Cue Biopharma Inc. | CUE | Kiener Peter A Director |
24,400 | $0 | 24,400 (Direct) |
View |
| 2024-11-25 Option Award |
2024-11-29 4:00 pm |
N/A 2034-11-24 |
Cue Biopharma Inc. | CUE | Baker Daniel G. CHIEF DEVELOPMENT OFFICER |
200,000 | $0 | 200,000 (Direct) |
View |
| 2024-09-03 Option Award |
2024-09-05 4:00 pm |
N/A 2034-09-02 |
Cue Biopharma Inc. | CUE | Warren Lucinda CHIEF BUSINESS OFFICER |
350,000 | $0 | 350,000 (Direct) |
View |
| 2024-06-05 Option Award |
2024-06-07 4:00 pm |
N/A 2034-06-04 |
Cue Biopharma Inc. | CUE | Levisetti Matteo Chief Medical Officer |
125,000 | $0 | 125,000 (Direct) |
View |
| 2024-06-05 Option Award |
2024-06-07 4:00 pm |
N/A 2034-06-04 |
Cue Biopharma Inc. | CUE | Suri Anish PRESIDENT AND CSO |
150,000 | $0 | 150,000 (Direct) |
View |
| 2024-06-05 Option Award |
2024-06-07 4:00 pm |
N/A 2034-06-04 |
Cue Biopharma Inc. | CUE | Fox Michael J Director |
48,800 | $0 | 48,800 (Direct) |
View |
| 2024-06-05 Option Award |
2024-06-07 4:00 pm |
N/A 2034-06-04 |
Cue Biopharma Inc. | CUE | Sandercock Colin SVP, GENERAL COUNSEL |
60,000 | $0 | 60,000 (Direct) |
View |
Ownership |
2024-06-07 4:00 pm |
N/A N/A |
Cue Biopharma Inc. | CUE | Fox Michael J Director |
0 | $0 | 1,100,000 (Indirect) |
View |
| 2024-06-05 Option Award |
2024-06-07 4:00 pm |
N/A 2034-06-04 |
Cue Biopharma Inc. | CUE | Millar Kerri-Ann CHIEF FINANCIAL OFFICER |
60,000 | $0 | 60,000 (Direct) |
View |
| 2024-03-06 Option Award |
2024-03-08 4:00 pm |
N/A 2034-03-05 |
Cue Biopharma Inc. | CUE | Sandercock Colin SVP, GENERAL COUNSEL |
175,000 | $0 | 175,000 (Direct) |
View |
| 2024-03-06 Option Award |
2024-03-08 4:00 pm |
N/A 2034-03-05 |
Cue Biopharma Inc. | CUE | Suri Anish PRESIDENT AND CSO |
300,000 | $0 | 300,000 (Direct) |
View |
| 2024-03-06 Option Award |
2024-03-08 4:00 pm |
N/A 2034-03-05 |
Cue Biopharma Inc. | CUE | Millar Kerri-Ann CHIEF FINANCIAL OFFICER |
250,000 | $0 | 250,000 (Direct) |
View |
| 2024-03-06 Option Award |
2024-03-08 4:00 pm |
N/A 2034-03-05 |
Cue Biopharma Inc. | CUE | PASSERI DANIEL R CHIEF EXECUTIVE OFFICER |
400,000 | $0 | 400,000 (Direct) |
View |
| 2024-03-06 Option Award |
2024-03-08 4:00 pm |
N/A 2034-03-05 |
Cue Biopharma Inc. | CUE | Levisetti Matteo Chief Medical Officer |
260,000 | $0 | 260,000 (Direct) |
View |
| 2024-02-20 Option Award |
2024-02-22 4:00 pm |
N/A 2033-01-16 |
Cue Biopharma Inc. | CUE | Levisetti Matteo Chief Medical Officer |
25,000 | $0 | 25,000 (Direct) |
View |
| 2024-01-02 Option Award |
2024-01-04 4:02 pm |
N/A 2034-01-01 |
Cue Biopharma Inc. | CUE | Garzone Pamela Director |
24,400 | $0 | 24,400 (Direct) |
View |
| 2024-01-02 Option Award |
2024-01-04 4:02 pm |
N/A 2034-01-01 |
Cue Biopharma Inc. | CUE | Kiener Peter A Director |
24,400 | $0 | 24,400 (Direct) |
View |
| 2024-01-02 Option Award |
2024-01-04 4:02 pm |
N/A 2034-01-01 |
Cue Biopharma Inc. | CUE | DRISCOLL FREDERICK W Director |
24,400 | $0 | 24,400 (Direct) |
View |
| 2024-01-02 Option Award |
2024-01-04 4:01 pm |
N/A 2034-01-01 |
Cue Biopharma Inc. | CUE | Verheyen Patrick Director |
24,400 | $0 | 24,400 (Direct) |
View |
| 2024-01-02 Option Award |
2024-01-04 4:00 pm |
N/A 2034-01-01 |
Cue Biopharma Inc. | CUE | Morich Frank Director |
24,400 | $0 | 24,400 (Direct) |
View |
| 2023-07-21 Option Award |
2023-07-25 12:33 pm |
N/A 2033-07-20 |
Cue Biopharma Inc. | CUE | Levisetti Matteo Chief Medical Officer |
82,500 | $0 | 82,500 (Direct) |
View |
| 2023-07-21 Option Award |
2023-07-25 12:31 pm |
N/A 2033-07-20 |
Cue Biopharma Inc. | CUE | Millar Kerri-Ann CHIEF FINANCIAL OFFICER |
113,000 | $0 | 113,000 (Direct) |
View |
| 2023-07-21 Option Award |
2023-07-25 12:28 pm |
N/A 2033-07-20 |
Cue Biopharma Inc. | CUE | PASSERI DANIEL R CHIEF EXECUTIVE OFFICER |
450,000 | $0 | 450,000 (Direct) |
View |